| Nome |
# |
|
Efficacy of sodium thiosulphate in a case of calciphylaxis in a chronic nephropathic ninety-year-old patient on conservative therapy, file e4233f17-4bea-2860-e053-6605fe0a460a
|
560
|
|
Use of oral hypoglycemic agents in patients with chronic kidney failure, file e4233f14-f92c-2860-e053-6605fe0a460a
|
241
|
|
Vitamin E (Alpha-Tocopherol) Metabolism and Nutrition in Chronic Kidney Disease, file e4233f19-6877-2860-e053-6605fe0a460a
|
61
|
|
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations, file e4233f17-b9aa-2860-e053-6605fe0a460a
|
60
|
|
A Novel Formulation of Glucose-Sparing Peritoneal Dialysis Solutions with l-Carnitine Improves Biocompatibility on Human Mesothelial Cells, file e4233f18-3230-2860-e053-6605fe0a460a
|
53
|
|
Uremic toxicity and anemia, file e4233f16-a902-2860-e053-6605fe0a460a
|
48
|
|
Extra-hepatic manifestations associated with Hepatitis and virus infection, file e4233f16-db6b-2860-e053-6605fe0a460a
|
38
|
|
Therapy of glucocorticoid induced osteoporosis, file e4233f16-df2e-2860-e053-6605fe0a460a
|
38
|
|
Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure, file e4233f16-2523-2860-e053-6605fe0a460a
|
36
|
|
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy, file e4233f17-d609-2860-e053-6605fe0a460a
|
22
|
|
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression, file e4233f14-eb6b-2860-e053-6605fe0a460a
|
20
|
|
Effect of erythropoietin on primed leucocyte expression profile., file e4233f15-bd24-2860-e053-6605fe0a460a
|
20
|
|
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells, file e4233f15-dbec-2860-e053-6605fe0a460a
|
19
|
|
Urinary Peptidomic Biomarkers in Kidney Diseases, file e4233f17-6925-2860-e053-6605fe0a460a
|
19
|
|
Alterazioni eritrocitarie e loro possibile ruolo nelle complicanze cardiovascolari dell’uremia, file e4233f17-f259-2860-e053-6605fe0a460a
|
19
|
|
Biological effects of XyloCore, a glucose sparing PD solution, on mesothelial cells: focus on mesothelial-mesenchymal transition, inflammation and angiogenesis, file e4233f18-ca30-2860-e053-6605fe0a460a
|
19
|
|
The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis, file e4233f18-bdb6-2860-e053-6605fe0a460a
|
18
|
|
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients, file e4233f15-a5f5-2860-e053-6605fe0a460a
|
17
|
|
Removal of uremic plasma factors using different dialysis modalities, file e4233f16-a38e-2860-e053-6605fe0a460a
|
17
|
|
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis., file e4233f17-8d05-2860-e053-6605fe0a460a
|
17
|
|
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients, file e4233f19-7421-2860-e053-6605fe0a460a
|
17
|
|
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells, file e4233f14-fa82-2860-e053-6605fe0a460a
|
16
|
|
L-Carnitine is an osmotic agent suitable for peritoneal dialysis, file e4233f15-a44c-2860-e053-6605fe0a460a
|
16
|
|
Erythrocyte alterations and increased cardiovascular risk in chronic renal failure, file e4233f16-2860-2860-e053-6605fe0a460a
|
16
|
|
Proteomic Research in Peritoneal Dialysis, file e4233f17-cf17-2860-e053-6605fe0a460a
|
16
|
|
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression, file e4233f14-eb6c-2860-e053-6605fe0a460a
|
14
|
|
Prognostic value of morphologic and morphometric analyses in IgA nephropathy biopsies, file e4233f16-1aec-2860-e053-6605fe0a460a
|
14
|
|
Current opinion on usage of L-carnitine in end-stage renal disease patients on peritoneal dialysis, file e4233f17-49ed-2860-e053-6605fe0a460a
|
14
|
|
Quali soluzioni future per la dialisi peritoneale?, file e4233f18-9d75-2860-e053-6605fe0a460a
|
14
|
|
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells, file e4233f14-ed38-2860-e053-6605fe0a460a
|
12
|
|
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis, file e4233f16-d6f0-2860-e053-6605fe0a460a
|
12
|
|
Calcimimetic R-568 vasodilatory effect effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs), file e4233f16-db0e-2860-e053-6605fe0a460a
|
12
|
|
Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report study, file e4233f18-bbd0-2860-e053-6605fe0a460a
|
12
|
|
Metabolic Syndrome in Survivors from the 2009 Earthquake in Italy, file e4233f15-03cf-2860-e053-6605fe0a460a
|
11
|
|
Blood cell proteomics in chronic kidney disease, file e4233f16-e135-2860-e053-6605fe0a460a
|
11
|
|
A New Peritoneal Dialysis Solution Containing L‐Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience, file e4233f18-4d2d-2860-e053-6605fe0a460a
|
11
|
|
New treatment approaches for the anemia of CKD, file e4233f16-2294-2860-e053-6605fe0a460a
|
10
|
|
Biocompatibility of DIAPES, file e4233f16-a38c-2860-e053-6605fe0a460a
|
10
|
|
null, file e4233f17-dd9a-2860-e053-6605fe0a460a
|
10
|
|
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis, file e4233f18-6b54-2860-e053-6605fe0a460a
|
10
|
|
Identification of trimethylamine N-oxide (TMAO)-producer phenotype is interesting, but is it helpful?, file e4233f17-5f8d-2860-e053-6605fe0a460a
|
9
|
|
Calcium Sensing Receptor Expression in Ovine Amniotic
Fluid Mesenchymal Stem Cells and the Potential Role of
R-568 during Osteogenic Differentiation, file e4233f15-06c4-2860-e053-6605fe0a460a
|
8
|
|
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey, file e4233f18-7115-2860-e053-6605fe0a460a
|
8
|
|
IgA Deficiency and Membranoproliferative Glomerulonephritis: A Case Report, file e4233f18-a0b4-2860-e053-6605fe0a460a
|
8
|
|
How to improve the biocompatibility of peritoneal dialysis solutions (without Jeopardizing the patient’s health), file e4233f18-b1f4-2860-e053-6605fe0a460a
|
8
|
|
Post-dialysis fatigue and survival in patients on chronic hemodialysis, file e4233f18-bf50-2860-e053-6605fe0a460a
|
8
|
|
Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis, file e4233f19-1874-2860-e053-6605fe0a460a
|
8
|
|
null, file 93783007-64bb-4d07-b64e-9583bec9eefe
|
7
|
|
Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter, file e4233f15-c147-2860-e053-6605fe0a460a
|
7
|
|
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study, file 8d96b337-4f84-4ef2-a13a-f7ab032755c0
|
6
|
|
Plasma protein carbonylation in chronic uremia, file e4233f14-f8f8-2860-e053-6605fe0a460a
|
6
|
|
Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations, file e4233f15-1456-2860-e053-6605fe0a460a
|
6
|
|
Update sull'impiego della proteomica in emodialisi, file e4233f16-285d-2860-e053-6605fe0a460a
|
6
|
|
Prevalence and severity of postdialysis fatigue are higher in patients on chronic hemodialysis with functional disability, file e4233f16-fe04-2860-e053-6605fe0a460a
|
6
|
|
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy, file e4233f18-e1ef-2860-e053-6605fe0a460a
|
6
|
|
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia, file e4233f14-ebf7-2860-e053-6605fe0a460a
|
5
|
|
Proteomics and nephrology, file e4233f14-ff70-2860-e053-6605fe0a460a
|
5
|
|
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations, file e4233f17-83a2-2860-e053-6605fe0a460a
|
5
|
|
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy, file e4233f19-1f7b-2860-e053-6605fe0a460a
|
5
|
|
Proteomics characterization of protein adsorption onto hemodialysis membranes, file e4233f14-eb29-2860-e053-6605fe0a460a
|
4
|
|
Dialysis practice and patient outcome in the aftermath of the earthquake at L'Aquila, Italy, April 2009, file e4233f14-f814-2860-e053-6605fe0a460a
|
4
|
|
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial., file e4233f15-0503-2860-e053-6605fe0a460a
|
4
|
|
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation., file e4233f15-06f1-2860-e053-6605fe0a460a
|
4
|
|
Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells., file e4233f16-a356-2860-e053-6605fe0a460a
|
4
|
|
Prevalence and associated variables of postdialysis fatigue: results of a prospective multicenter study, file e4233f16-df28-2860-e053-6605fe0a460a
|
4
|
|
Carnitine in metabolic disease: potential for pharmacological intervention, file e4233f14-ebf8-2860-e053-6605fe0a460a
|
3
|
|
Dialysis practice and patient outcome in the aftermath of the earthquake at L'Aquila, Italy, April 2009, file e4233f14-f813-2860-e053-6605fe0a460a
|
3
|
|
Management of IgA nephropathy, file e4233f14-f81a-2860-e053-6605fe0a460a
|
3
|
|
null, file e4233f16-25c5-2860-e053-6605fe0a460a
|
3
|
|
Examining hemodialyzer membrane performance using proteomic technologies, file e4233f16-899b-2860-e053-6605fe0a460a
|
3
|
|
Defining the potential antidepressant mode of action of acetyl-l-carnitine., file e4233f16-db70-2860-e053-6605fe0a460a
|
3
|
|
Valutazione psicologica del paziente in trattamento dialitico cronico: comparazione tra tecniche sostitutive domiciliari e ospedaliere, file e4233f18-b7d1-2860-e053-6605fe0a460a
|
3
|
|
Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis, file e4233f18-e262-2860-e053-6605fe0a460a
|
3
|
|
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia, file e4233f14-ebf6-2860-e053-6605fe0a460a
|
2
|
|
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine, file e4233f14-ebfd-2860-e053-6605fe0a460a
|
2
|
|
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine, file e4233f14-ebfe-2860-e053-6605fe0a460a
|
2
|
|
Carnitine palmitoyltransferase as a potential target for treating diabetes: is inhibition or activation preferable?, file e4233f14-f816-2860-e053-6605fe0a460a
|
2
|
|
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici], file e4233f14-f817-2860-e053-6605fe0a460a
|
2
|
|
Serum fetuin-a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?, file e4233f14-f926-2860-e053-6605fe0a460a
|
2
|
|
Serum fetuin-a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?, file e4233f14-f927-2860-e053-6605fe0a460a
|
2
|
|
Leukapheresis and chronic inflammatory bowel disease: an additional obligation for the nephrologist, file e4233f14-fefe-2860-e053-6605fe0a460a
|
2
|
|
Prognosis of CKD patients receiving outpatient nephrology care in Italy, file e4233f14-ff02-2860-e053-6605fe0a460a
|
2
|
|
Proteomic Investigations into Hemodialysis Therapy, file e4233f15-49a9-2860-e053-6605fe0a460a
|
2
|
|
Increased erythrocyte phosphatidylserine exposure in chronic renal failure, file e4233f16-2a68-2860-e053-6605fe0a460a
|
2
|
|
Epatotossicità acuta da amiodarone endovena in una paziente in emodialisi, file e4233f16-2b56-2860-e053-6605fe0a460a
|
2
|
|
Proteomics and protein adsorption on hemodialysis membranes, file e4233f16-8b36-2860-e053-6605fe0a460a
|
2
|
|
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander?, file e4233f16-aae5-2860-e053-6605fe0a460a
|
2
|
|
Platelet activation markers in patients with nephrotic syndrome: A comparative study of different platelet function tests, file e4233f16-abf9-2860-e053-6605fe0a460a
|
2
|
|
Glomerulopathies associated with psoriasis: a report of three cases, file e4233f16-acdf-2860-e053-6605fe0a460a
|
2
|
|
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis, file e4233f16-ace1-2860-e053-6605fe0a460a
|
2
|
|
Recovery time after hemodialysis is inversely associated with the ultrafiltration rate., file e4233f16-fa64-2860-e053-6605fe0a460a
|
2
|
|
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial, file e4233f19-172f-2860-e053-6605fe0a460a
|
2
|
|
null, file e4233f19-2f50-2860-e053-6605fe0a460a
|
2
|
|
null, file bdd467b7-623d-48df-8556-c67cd18f1efe
|
1
|
|
Reduced nitric oxide bioavailability in chronic renal failure: a new factor of progression?, file e4233f14-e935-2860-e053-6605fe0a460a
|
1
|
|
Potential mode of action of L-carnitine on uraemic anaemia, file e4233f14-ebfa-2860-e053-6605fe0a460a
|
1
|
|
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells, file e4233f14-ed39-2860-e053-6605fe0a460a
|
1
|
|
In vitro microbiology studies on a new peritoneal dialysis connector, file e4233f14-f81b-2860-e053-6605fe0a460a
|
1
|
|
Effect of computer-assisted European Best Practice Guideline implementation on adherence and target attainment: ORAMA results, file e4233f14-ff06-2860-e053-6605fe0a460a
|
1
|
|
L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis, file e4233f15-0b9d-2860-e053-6605fe0a460a
|
1
|
| Totale |
1822 |